| Literature DB >> 34084398 |
Liping Zhang1, Weilong Che1, Zhiyu Yang2, Xingman Liu1, Shi Liu2, Zhigang Xie2, Dongxia Zhu1, Zhongmin Su1, Ben Zhong Tang3, Martin R Bryce4.
Abstract
Developing multifunctional photosensitizers (PSs) is needed to effectively simplify cancer treatment, but it remains a big challenge. Here, two red-emitting AIE-active, donor-acceptor (D-A) PSs with small ΔE ST and their AIE nanoparticles, are rationally designed and synthesized. The PS1 NPs exhibit bright red-emission with high quantum yield, appropriate 1O2 generation ability and good biocompatibility. More importantly, PS1 NPs can strongly light up the cytoplasm by gently shaking the cells for only 5 s at room temperature, indicating ultrafast staining and mild incubation conditions. In vitro and in vivo cell tracing demonstrate that PS1 NPs can track cells over 14 days, and effectively inhibit tumor growth upon irradiation. To the best of our knowledge, this work is the first example of a PS that integrates image-guided PDT, ultrafast staining and long-term tracing functions, demonstrating the "all-in-one" concept which offers great advantages for potential clinical applications. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 34084398 PMCID: PMC8157307 DOI: 10.1039/c9sc06310b
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Fig. 1(A) Structural formulas of PS1 and PS2. (B) Schematic illustration of PS1 NPs as PSs for “all-in-one” PDT.
Fig. 2(A) HOMO and LUMO distributions of PS1 and PS2 based on TD-DFT. UV-vis and emission spectroscopies of (B) PS1 and (C) PS2 in DMSO, DMSO/water (v/v) = 1/9, and the corresponding PS NPs in water (λex = 488 nm), insert: the fluorescent image of PSs and their NPs under 365 nm UV light. (D) The decomposition rates of ICG with different PSs under white irradiation (20 mW cm−2). (E) Size measurement of different PSs in 14 days, insert: the TEM images of (a) PS1 NPs and (b) PS2 NPs.
Fig. 3Viability of HeLa cells treated with (A) PS1 NPs and (B) PS2 NPs with or without white light (20 mW cm−2, 60 min). (C) CLSM images of HeLa cells after incubation with PS1 NPs (3 μg mL−1) for different times. (D) Long-term cell tracing images of the PS1 NPs (20 μg mL−1) at 37 °C for 6 h and then subcultured for a different number of days. Scale bar = 20 μm for all images.
Fig. 4(A) Time-dependent in vivo fluorescence images of U14 tumor-bearing mice after intratumoral injection with PS1 NPs (100 μg mL−1, 100 μL) or with PS1 NPs + white light (200 mW cm−2, 20 min). (B) Harvested tumors from various groups treated. (C) Fluorescence intensity of U14 tumor-bearing mice in different mice groups. (D) Tumor volume measurement for different treatments of mice (***P < 0.001, n = 4 per group, PDT vs. other groups). (E) H&E staining images of tumor slices from each groups. Scale bars: 100 μm. (a) With saline, (b) with saline and light, (c) with PS1 NPs, (d) with PS1 NPs and light (100 μg mL−1, 100 μL), white light (200 mW cm−2, 20 min).